Genetic testing to guide statin choice for veterans
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at using a genetic test to help doctors choose the best statin medicine for veterans who need to lower their cholesterol but haven't taken a statin in the last 6 months. If you have diabetes, heart disease, or have had a stroke, this trial may help find a statin that works well for you with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a U.S. military veteran.
- You are between 40 and 75 years old.
- You have diabetes, coronary artery disease, or a history of stroke or blocked leg arteries.
- You have a primary care appointment at the VA within the next 4 months.
- You have not taken any statin medication (from any doctor) in the last 6 months.
- You have at least one current VA prescription and have seen a VA primary care provider in the past 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cholesterol-lowering drug called Hybutimibe for people who are already taking a moderate-dose statin but still have high LDL (bad) cholesterol. It aims to see how well the drug works based on your genes.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This trial tests a one-time gene therapy (NGGT006) to treat a severe form of inherited high cholesterol that doesn't respond well to standard medications. It aims to lower cholesterol and reduce the risk of heart disease.
This trial tests a new gene therapy called YOLT-101 for people with familial hypercholesterolemia, a genetic condition that causes very high cholesterol. The treatment aims to lower cholesterol levels and reduce heart risks.
This early study tests whether “liver fat” changes how a statin (rosuvastatin) works in children and teens. It may help doctors choose safer or more effective dosing in kids based on biology and a specific genetics marker.
This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.
Hear when a new Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.